WHP is a national innovator in the prevention of “vertical transmission” of HIV from mother to child.
We are now also playing a leading role in the new field of using antiretroviral medications to prevent HIV negative people from contracting the virus, Pre-Exposure Prophylaxis (PrEP). Providers at WHP were among the first in the country to develop research and programs to prevent mother to child transmission of the virus. Because of this work, HIV-positive women can now become pregnant and deliver HIV negative infants with near certainty that they will not transmit the virus. Our lead obstetrician, Deb Cohan MD [link to her bio], is a widely published national leader in developing guidelines for the successful prevention of the transmission of the virus from mother to child. She uses this knowledge to help WHP patients become mothers of healthy and happy babies.
Dr. Cohan is also a national leader in developing guidelines for the use of HIV medications in high-risk HIV negative individuals to prevent their getting infected with the virus. Pre-Exposure Prophylaxis (PrEP), holds great potential to harness powerful medications to prevent HIV in high-risk populations such as women of color.